Concepedia

Jeffrey Spond

JS

6

Publications

292

Citations

6

H-Index

2001

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Jeffrey Spond is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in inflammatory lung disease, inflammation, and medicine.

Top concepts

Publications per year

2001–2016

6

Publications

6

2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 3 – Lba, Biomarkers and Immunogenicity)

Lakshmi Amaravadi, An Song, Heather Myler et al. · Bioanalysis · 2015 · 74 citations · Full text

Comparison of PDE 4 Inhibitors, Rolipram and SB 207499 (ArifloTM, in a Rat Model of Pulmonary Neutrophilia

Jeffrey Spond, Richard W. Chapman, Jay S. Fine et al. · Pulmonary Pharmacology & Therapeutics · 2001 · 56 citations

, , +9

Inhibition of experimental acute pulmonary inflammation by pirfenidone

Jeffrey Spond, Natalie R. Case, Richard W. Chapman et al. · Pulmonary Pharmacology & Therapeutics · 2003 · 55 citations

, , +7

A Candidate Plasma Protein Classifier to Identify Alzheimer's Disease

Xuemei Zhao, Serguei Lejnine, Jeffrey Spond et al. · Journal of Alzheimer s Disease · 2014 · 41 citations

The role of neutrophils in LPS-induced changes in pulmonary function in conscious rats

Jeffrey Spond, Motasim Billah, Richard W. Chapman et al. · Pulmonary Pharmacology & Therapeutics · 2004 · 39 citations

, , +11

Rows per page

1–5 of 6